Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Lantern Pharma Inc. (LTRN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/24/2022 |
4
| Maccecchini Maria-Luisa (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options to buy
@ $4.79, valued at
$15.3k
|
|
09/07/2022 |
4
| Fletcher Aaron G.L. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Sold 5,170 shares
@ $5.2, valued at
$26.9k
Sold 1,275 shares
@ $5.2, valued at
$6.6k
Exercised (in-or-at-the-money) 26,100 options
@ $1.03, valued at
$26.9k
Exercised (in-or-at-the-money) 6,438 options
@ $1.03, valued at
$6.6k
|
|
09/07/2022 |
4
| Kreis Leslie W. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Sold 5,170 shares
@ $5.2, valued at
$26.9k
Sold 1,275 shares
@ $5.2, valued at
$6.6k
Exercised (in-or-at-the-money) 26,100 options
@ $1.03, valued at
$26.9k
Exercised (in-or-at-the-money) 6,438 options
@ $1.03, valued at
$6.6k
|
|
08/09/2022 |
4
| SHARMA PANNA (President and CEO) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 100,000 options to buy
@ $5.6, valued at
$560k
|
|
03/21/2022 |
4
| Kreis Leslie W. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Exercised (in-or-at-the-money) 60,432 shares
@ $189152.16, valued at
$11430.8M
Exercised (in-or-at-the-money) 35,347 shares
@ $110636.11, valued at
$3910.7M
Exercised (in-or-at-the-money) 60,432 options to buy
@ $0 Exercised (in-or-at-the-money) 35,347 options to buy
@ $0 |
|
11/08/2021 |
4
| Kreis Leslie W. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options
@ $10.32, valued at
$33k
|
|
11/08/2021 |
4
| PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options to buy
@ $10.32, valued at
$33k
|
|
11/08/2021 |
4
| Chandru Vijay (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options to buy
@ $10.32, valued at
$33k
|
|
11/08/2021 |
4
| Silberstein David S. (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options to buy
@ $10.32, valued at
$33k
|
|
11/08/2021 |
4
| KEYSER D JEFFREY (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 3,200 options to buy
@ $10.32, valued at
$33k
|
|
11/02/2021 |
4
| Bhatia Kishor G. (Chief Scientific Officer) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 17,400 options to buy
@ $10.21, valued at
$177.7k
|
|
11/02/2021 |
4
| Margrave David R. (CFO) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 26,100 options to buy
@ $10.21, valued at
$266.5k
|
|
01/19/2021 |
4
| Green Park & Golf Ventures II, LLC (Fmr 10% Owner (see "Remarks")) has filed a Form 4 on Lantern Pharma Inc. |
06/17/2020 |
4
| Green Park & Golf Ventures II, LLC (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Converted 41,535 shares
@ $0 Converted 292,605 shares
@ $0 Converted 131,697 shares
@ $0 Converted 23,871 options to buy
@ $0 Converted 168,164 options to buy
@ $0 Converted 75,688 options to buy
@ $0 |
|
06/16/2020 |
4
| Fletcher Aaron G.L. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Converted 503,606 shares
@ $0 Converted 294,557 shares
@ $0 Converted 139,989 shares
@ $0 Converted 457,282 shares
@ $0 Converted 61,214 shares
@ $0 Converted 289,429 preferred shares
@ $0 Converted 169,286 preferred shares
@ $0 Converted 80,454 preferred shares
@ $0 Converted 262,806 preferred shares
@ $0 Converted 35,181 preferred shares
@ $0 Acquired 9,135 options
@ $15, valued at
$137k
|
|
06/16/2020 |
4
| Kreis Leslie W. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Converted 503,606 shares
@ $0 Converted 294,557 shares
@ $0 Converted 139,989 shares
@ $0 Converted 457,282 shares
@ $0 Converted 61,214 shares
@ $0 Converted 289,429 preferred shares
@ $0 Converted 169,286 preferred shares
@ $0 Converted 80,454 preferred shares
@ $0 Converted 262,806 preferred shares
@ $0 Converted 35,181 preferred shares
@ $0 Granted 9,135 options
@ $15, valued at
$137k
|
|
06/15/2020 |
4
| Chandru Vijay (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 9,135 options
@ $0 |
|
06/15/2020 |
4
| SHARMA PANNA (CEO & President) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 76,628 options
@ $0 |
|
06/15/2020 |
4
| Bhatia Kishor G. (Chief Scientific Officer) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 52,200 options
@ $0 |
|
06/15/2020 |
4
| PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 9,135 options
@ $0 |
|
06/15/2020 |
4
| Silberstein David S. (10% Owner) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 9,135 options
@ $0 |
|
06/15/2020 |
4
| Margrave David R. (CFO and Secretary) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Granted 78,300 options
@ $0 |
|
06/15/2020 |
4
| Asaithambi Arunkumar (Previous 10% Owner) has filed a Form 4 on Lantern Pharma Inc. |
06/15/2020 |
4
| KEYSER D JEFFREY (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Converted 31,927 shares
@ $0 Converted 18,349 preferred shares
@ $0 Granted 9,135 options
@ $0 |
|
06/15/2020 |
4
| KEYSER D JEFFREY (Director) has filed a Form 4 on Lantern Pharma Inc.
Txns:
| Bought 10,000 shares
@ $15, valued at
$150k
|
|
|
|